Alpha Profiles · Company Profile

Revolution Medicines, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/revolution-medicines-inc

Entity: Public listing published
Primary listing: NASDAQ: RVMD
Verification: Partially verified
Last reviewed: 2026-09-13T04:48:09.70381+00:00

Overview

Alpha's canonical identity and public leadership record for Revolution Medicines, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Alan Sandler

Chief Development Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Anthony Mancini

Chief Global Commercialization Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Jack Anders

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Jeffrey Cislini

Senior Vice President, General Counsel and Secretary

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Margaret Horn

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Mark A. Goldsmith

Chief Executive Officer, President and Chair of the Board

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Stephen M. Kelsey

President, Research and Development

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: RVMD executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.